Novus Biologicals Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 1

Novus Biologicals General Information

Description

Provider of research tools intended to accelerate scientific discovery. The company provides primary and secondary antibodies, peptides, proteins, kits, controls, lysates, RNAi and other ancillary products and reagents for life science research, thereby helping in studying protein functions in the fields of cancer, neuroscience, autophagy, lipid and cardiovascular research.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Corporate Office
  • 10771 East Easter Avenue
  • Suite A-Eight
  • Centennial, CO 80120
  • United States
+1 (303)
Primary Industry
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • 10771 East Easter Avenue
  • Suite A-Eight
  • Centennial, CO 80120
  • United States
+1 (303)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novus Biologicals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novus Biologicals‘s full profile, request access.

Request a free trial

Novus Biologicals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of research tools intended to accelerate scientific discovery. The company provides primary and secondary antib
Biotechnology
Centennial, CO

Irvine, CA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Novus Biologicals Competitors (40)

One of Novus Biologicals’s 40 competitors is GeneTex, a Formerly VC-backed company based in Irvine, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GeneTex Formerly VC-backed Irvine, CA
Aviva Systems Biology Formerly VC-backed San Diego, CA
Jackson ImmunoResearch Laboratories Corporation West Grove, PA
Abcam Corporate Backed or Acquired Cambridge, United Kingdom
ProSci (Biotechnology) Private Equity-Backed Poway, CA
You’re viewing 5 of 40 competitors. Get the full list »

Novus Biologicals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Novus Biologicals‘s full profile, request access.

Request a free trial

Novus Biologicals Investments (1)

Novus Biologicals’s most recent deal was a Buyout/LBO with Imgenex. The deal was made on 30-Oct-2013.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Imgenex 30-Oct-2013 Buyout/LBO Discovery Tools (Healthcare)
To view Novus Biologicals’s complete investments history, request access »

Novus Biologicals FAQs

  • When was Novus Biologicals founded?

    Novus Biologicals was founded in 1996.

  • Where is Novus Biologicals headquartered?

    Novus Biologicals is headquartered in Centennial, CO.

  • What industry is Novus Biologicals in?

    Novus Biologicals’s primary industry is Biotechnology.

  • Is Novus Biologicals a private or public company?

    Novus Biologicals is a Private company.

  • What is the current valuation of Novus Biologicals?

    The current valuation of Novus Biologicals is .

  • What is Novus Biologicals’s current revenue?

    The current revenue for Novus Biologicals is .

  • Who are Novus Biologicals’s investors?

    Mainsail Partners has invested in Novus Biologicals.

  • Who are Novus Biologicals’s competitors?

    GeneTex, Aviva Systems Biology, Jackson ImmunoResearch Laboratories, Abcam, and ProSci (Biotechnology) are some of the 40 competitors of Novus Biologicals.

  • When was Novus Biologicals acquired?

    Novus Biologicals was acquired on 03-Jul-2014.

  • Who acquired Novus Biologicals?

    Novus Biologicals was acquired by Bio-Techne.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process